FORMAC Pharmaceuticals NV - Company Review
SummaryFORMAC Pharmaceuticals NV - Company Review
Summary
Formac Pharmaceuticals NV (Formac) is a drug delivery company that formulates poorly soluble active pharmaceutical ingredients. The company and markets mesoporous silica materials. It uses technology is based on the use of mesoporous silica materials serving as stabilizers for the amorphous form of the API solution. Formac’s technology is utilized to enhance apparent solubility and dissolution rate, physical and chemical stability, processing tablets, and others. The company serves through distributors to pharmaceutical companies, and human and veterinary medicine enterprises. It partners with life sciences research companies. FORMAC is headquartered in Heverlee, Belgium.
This comprehensive company report of FORMAC Pharmaceuticals NV provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.